GW572016 For Treatment Of Refractory Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Neoplasms, Breast
Interventions: DRUG: GW572016
Sponsor: GlaxoSmithKline